112 related articles for article (PubMed ID: 9689813)
1. Recurrent chromosome 6 abnormalities in malignant mesothelioma.
Ribotta M; Roseo F; Salvio M; Castagneto B; Carbone M; Procopio A; Giordano A; Mutti L
Monaldi Arch Chest Dis; 1998 Apr; 53(2):228-35. PubMed ID: 9689813
[TBL] [Abstract][Full Text] [Related]
2. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma.
Taguchi T; Jhanwar SC; Siegfried JM; Keller SM; Testa JR
Cancer Res; 1993 Sep; 53(18):4349-55. PubMed ID: 8364929
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic analysis of malignant mesothelioma.
Hagemeijer A; Versnel MA; Van Drunen E; Moret M; Bouts MJ; van der Kwast TH; Hoogsteden HC
Cancer Genet Cytogenet; 1990 Jul; 47(1):1-28. PubMed ID: 2357680
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma.
Tiainen M; Tammilehto L; Rautonen J; Tuomi T; Mattson K; Knuutila S
Br J Cancer; 1989 Oct; 60(4):618-26. PubMed ID: 2803935
[TBL] [Abstract][Full Text] [Related]
5. Malignant mesothelioma: clinical characteristics, asbestos mineralogy and chromosomal abnormalities of 41 patients.
Tammilehto L; Tuomi T; Tiainen M; Rautonen J; Knuutila S; Pyrhönen S; Mattson K
Eur J Cancer; 1992; 28A(8-9):1373-9. PubMed ID: 1325175
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of chromosomes 7 and 22 in human malignant pleural mesothelioma: correlation between Southern blot and cytogenetic analyses.
Tiainen M; Kere J; Tammilehto L; Mattson K; Knuutila S
Genes Chromosomes Cancer; 1992 Mar; 4(2):176-82. PubMed ID: 1373319
[TBL] [Abstract][Full Text] [Related]
7. Nonrandom chromosomal abnormalities in malignant pleural mesothelioma.
Tiainen M; Tammilehto L; Mattson K; Knuutila S
Cancer Genet Cytogenet; 1988 Jul; 33(2):251-74. PubMed ID: 3164248
[TBL] [Abstract][Full Text] [Related]
8. Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: possible sites of tumor suppressor genes.
Flejter WL; Li FP; Antman KH; Testa JR
Genes Chromosomes Cancer; 1989 Nov; 1(2):148-54. PubMed ID: 2487155
[TBL] [Abstract][Full Text] [Related]
9. Karyotypic changes in the preclinical and subsequent stages of malignant mesothelioma: a case report.
Hansteen IL; Hilt B; Lien JT; Skaug V; Haugen A
Cancer Genet Cytogenet; 1993 Oct; 70(2):94-8. PubMed ID: 7694791
[TBL] [Abstract][Full Text] [Related]
10. del(6q) as a possible primary change in malignant mesothelioma.
Meloni AM; Stephenson CF; Li FP; Sandberg AA
Cancer Genet Cytogenet; 1992 Mar; 59(1):57-61. PubMed ID: 1555192
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal deletion in patients with malignant pleural mesothelioma.
Neragi-Miandoab S; Sugarbaker DJ
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):42-4. PubMed ID: 19346221
[TBL] [Abstract][Full Text] [Related]
12. [Clonal chromosome abnormalities in a case of pleural mesothelioma].
Pegoraro M; Bersi M; Gasparini C; Cardini G; Ruffoni A
Arch Sci Med (Torino); 1973; 130(2):125-30. PubMed ID: 17342920
[TBL] [Abstract][Full Text] [Related]
13. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma.
Murthy SS; Testa JR
J Cell Physiol; 1999 Aug; 180(2):150-7. PubMed ID: 10395284
[TBL] [Abstract][Full Text] [Related]
14. Interphase cytogenetics on paraffin sections of malignant pleural mesothelioma. A comparison to conventional karyotyping and flow cytometric studies.
Tiainen M; Hopman A; Moesker O; Ramaekers F; Wessman M; Laasonen A; Pyrhönen S; Tammilehto L; Mattson K; Knuutila S
Cancer Genet Cytogenet; 1992 Sep; 62(2):171-9. PubMed ID: 1394105
[TBL] [Abstract][Full Text] [Related]
15. Detection of numerical chromosomal aberrations in paraffin-embedded malignant pleural mesothelioma by non-isotopic in situ hybridization.
Segers K; Ramael M; Singh SK; Van Daele A; Weyler J; Van Marck E
J Pathol; 1995 Feb; 175(2):219-26. PubMed ID: 7738718
[TBL] [Abstract][Full Text] [Related]
16. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
[TBL] [Abstract][Full Text] [Related]
17. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology.
Matsumoto S; Nabeshima K; Kamei T; Hiroshima K; Kawahara K; Hata S; Marukawa K; Matsuno Y; Taguchi K; Tsujimura T
Cancer Cytopathol; 2013 Aug; 121(8):415-22. PubMed ID: 23450849
[TBL] [Abstract][Full Text] [Related]
18. Detection of numerical aberrations of chromosomes 7 and 9 in cytologic specimens of pleural malignant mesothelioma.
Shin HJ; Shin DM; Tarco E; Sneige N
Cancer; 2003 Aug; 99(4):233-9. PubMed ID: 12925985
[TBL] [Abstract][Full Text] [Related]
19. Comparative genomic hybridisation in malignant deciduoid mesothelioma.
Scattone A; Pennella A; Gentile M; Musti M; Nazzaro P; Buonadonna AL; Marzullo A; Cavone D; Pollice L; Serio G
J Clin Pathol; 2006 Jul; 59(7):764-9. PubMed ID: 16569690
[TBL] [Abstract][Full Text] [Related]
20. Chromosome number correlates with survival in patients with malignant pleural mesothelioma.
Tiainen M; Rautonen J; Pyrhönen S; Tammilehto L; Mattson K; Knuutila S
Cancer Genet Cytogenet; 1992 Aug; 62(1):21-4. PubMed ID: 1521229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
